Peptide/Health/News

NoticeInformation only. Not medical advice. Nothing here is a recommendation to use any substance. Read full disclaimer

← News
TrialClinical trialPHN-02562026-06-14 19:00 CT

A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

Source · ClinicalTrials.gov: survodutide

TLDR

A ClinicalTrials.gov listing reports a completed study comparing 2 formulations of survodutide delivered by pre-filled syringe or pen-like injector in healthy people, including those with overweight or obesity. The study assessed whether uptake in the body was similar; the excerpt provides no results.

01—Key points
  • 01The study is listed as completed.
  • 02Researchers compared formulations and delivery methods for similar uptake in the body.
  • 03Study visits included health assessments and blood sampling.

Why it matters Editorial

The study addresses whether survodutide formulations and delivery methods produce similar uptake, but the excerpt does not establish the outcome.

Read the original at ClinicalTrials.gov: survodutide↗

Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.

No related news yet.